Core Scientific’s stock found itself in focus after the dramatic breakdown of a planned merger. On Oct. 30 shareholders rejected CoreWeave’s $9 billion all-stock bidreuters.comdatacenterdynamics.com. Core Scientific said in a press release that it “did not receive the requisite number of votes” and therefore terminated the merger agreement, effective immediatelybusinesswire.com. The result came after weeks of proxy battles: major holder Two Seas Capital led a campaign saying the deal “materially undervalues” Core Scientificreuters.com, and ISS likewise urged a no-vote, reasoning that Core Scientific “has performed well on its own” and can keep growing independentlycoindesk.com.
